Skip to content

Research on Early Brain Injury in Systemic Lupus Erythematosus by Multimodal MRI

Research on Early Brain Injury in Systemic Lupus Erythematosus by Multimodal MRI

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102266
Enrollment
Unknown
Registered
2025-05-12
Start date
2025-05-15
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Lupus Erythematosus (SLE)

Interventions

Neuropsychiatric symptom:NA
Healthy control group:NA
No neuropsychiatric symptoms group:NA

Sponsors

The Affiliated Hospital of Inner Mongolia Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1.Inclusion criteria for the NPSLE group:(1) SLE with neuropsychiatric symptoms met the neuropsychiatric symptoms as defined by the 1999 ACR; (2) Age 18-55 years; (3) Female; (4) Right-handed ; (4) Can cooperate with MRl and neuropsychological examination; 2.Inclusion criteria for the non-NPSLE group: (1) Patients meeting the 2019 ACR criteria for SLE; (2) Patients without neuropsychiatric symptoms; (3) Age 18-55 years; (4) Female; (5) Right-handed ; (6) Can cooperate with MRl and neuropsychological examination; 3.Inclusion criteria for the healthy control group: (1) Age and gender were matched with those of the case group. (2) Right hand. (3) Other conditions were the same as those of the case group.

Exclusion criteria

Exclusion criteria: 1.Patients with serious diseases of other systems. 2. Patients with central nervous system diseases. 3. Other rheumatic immune system diseases. 4. History of neuropsychiatry. 5. Smokers, drug addicts or alcoholics. 6. Do not undergo MRI examinations. 7. Unable to cooperate with neuropsychological tests;

Design outcomes

Primary

MeasureTime frame
White matter/gray matter volume, cortical thickness, fMRI indicators (FC, ALFF and ReHo),;laboratory tests (lupus comprehensive items including antibodies, ANA, anti-dsDNA, anti-Sm, CRP, ESR, etc.);

Secondary

MeasureTime frame
Cognitive function scores;

Countries

China

Contacts

Public ContactPengfei Qiao

The Affiliated Hospital of Inner Mongolia Medical University

24853170@qq.com+86 15904718239

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026